A large study in older adults with type 2 diabetes finds that GLP-1 receptor agonists are associated with a modestly ...

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

Despite the $1,000-per-dose price tag, GLP-1s may offer long-term ROI by lowering chronic disease rates GLP-1 weight loss ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

Cigna (NYSE:CI) on Friday announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...